1q21.1 duplication syndrome
1q21.1 duplication syndrome is a rare genetic disorder that is caused by the duplication of a small piece of chromosome 1. The syndrome is characterized by a wide range of physical and mental developmental issues.
Symptoms[edit | edit source]
The symptoms of 1q21.1 duplication syndrome can vary greatly from person to person. Some individuals may have mild symptoms, while others may have severe symptoms. Common symptoms include intellectual disability, autism spectrum disorder, schizophrenia, heart defects, and abnormalities in the head and face (craniofacial anomalies).
Causes[edit | edit source]
1q21.1 duplication syndrome is caused by a duplication of a small piece of chromosome 1. This duplication can occur as a random event during the formation of reproductive cells or during early embryonic development. It can also be inherited from a parent who carries the duplication.
Diagnosis[edit | edit source]
The diagnosis of 1q21.1 duplication syndrome is typically made through genetic testing. This can include karyotyping, fluorescence in situ hybridization (FISH), and microarray analysis.
Treatment[edit | edit source]
There is currently no cure for 1q21.1 duplication syndrome. Treatment is focused on managing the symptoms and improving the quality of life for individuals with the syndrome. This can include physical therapy, occupational therapy, speech therapy, and educational support.
Prognosis[edit | edit source]
The prognosis for individuals with 1q21.1 duplication syndrome can vary greatly depending on the severity of the symptoms. Some individuals may have a normal life expectancy, while others may have a shortened life expectancy due to complications from heart defects or other health issues.
See also[edit | edit source]
- Chromosome 1
- Genetic disorder
- Intellectual disability
- Autism spectrum disorder
- Schizophrenia
- Heart defects
- Craniofacial anomalies
1q21.1 duplication syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD